Recombinant Pan troglodytes AF4/FMR2 family member 2 (AFF2), partial

Shipped with Ice Packs
In Stock

Description

Introduction

The AF4/FMR2 (AFF) family comprises nuclear transcriptional activators that facilitate RNA elongation . This family consists of four genes: AFF1/AF4, AFF2/FMR2, AFF3/LAF4, and AFF4/AF5q31, all located within the cell nuclei . These genes commonly participate in the regulation of splicing and transcription, although each member has distinct roles .

AFF2/FMR2 Gene

  • AFF2/FMR2: This gene is notably silenced in FRAXE intellectual disability . The other three genes in the family are known to form fusion genes as a result of chromosome translocations with the myeloid/lymphoid or mixed-lineage leukemia gene in acute lymphoblastic leukemias .

AF4/FMR2 in Drosophila

A Drosophila orthologue, named Lilliputian (Lilli; Q9VQI9), has been identified through research. Cells with a defective mutant of the Lilli gene are abnormally small . Lilli contains an AT-hook domain and functions as a pair-rule gene involved in cytoskeleton regulation, segmentation, and morphogenesis in Drosophila . Human AFF1 and AFF4, like Lilli, participate in the super elongation complex by linking positive elongation factor b (P-TEFb) and ELL1/2, regulating transcription through chromatin remodeling and elongation . The Lilli gene identifies potential, but not specific, FMR2 functions in humans and mice .

AFF3 and Autoimmune Diseases

AFF3 has been identified as a novel Rheumatoid Arthritis (RA) susceptibility locus .

Table 1: Association of AFF3 with Rheumatoid Arthritis Susceptibility

MarkerChrLocus/GeneHWE controlMAF caseMAF controlGenotype frequency cases (%)Genotype frequency controls (%)Trend P-valueAllelic OR (95% CI)
rs11605422AFF30.320.470.45833 (22.4) / 1033 (27.7) / 1493 (50.3)1860 (49.9) / 574 (19.3) / 900 (30.3)0.0011.12 (1.05–1.20)
rs108650352AFF30.260.490.46882 (24.2) / 976 (26.8) / 1488 (50.6)1786 (49.0) / 596 (20.3) / 854 (29.1)4.0 × 10−41.13 (1.06–1.21)
  • Chr = chromosome

  • HWE = Hardy-Weinberg equilibrium

  • MAF = minor allele frequency

  • OR = odds ratio

AFF4 Gene Information

AFF4, also known as AF4/FMR2 family member 4, is a protein-coding gene . It is a component of the positive transcription elongation factor b (P-TEFb) complex . Chromosomal translocations involving AFF4 and the MLL gene on chromosome 11 are found in infant acute lymphoblastic leukemia with ins(5;11)(q31;q31q23) . Diseases associated with AFF4 include CHOPS syndrome and heart septal defect .

Table 2: AFF4 Gene Details

Gene SymbolAFF4
Entrez Gene ID27125
Full NameAF4/FMR2 family member 4
SynonymsAF5Q31, CHOPS, MCEF
Gene Typeprotein-coding
OrganismHomo sapiens (human)

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during ordering for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a reference for customers.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt; aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
AFF2; FMR2AF4/FMR2 family member 2; Fragile X mental retardation protein 2 homolog; Protein FMR-2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Pan troglodytes (Chimpanzee)
Target Names
AFF2
Uniprot No.

Target Background

Function

RNA-binding protein potentially involved in regulating alternative splicing through interaction with G-quartet RNA structures.

Database Links
Protein Families
AF4 family
Subcellular Location
Nucleus speckle.

Q&A

What is AFF2 and what is its functional significance?

AFF2 (also known as FMR2) is a transcriptional factor and RNA-binding protein that plays a critical role in transcriptional regulation, RNA splicing, mRNA processing, and nuclear speckle organization . The gene is highly conserved evolutionarily and is abundantly expressed in the human brain, indicating its essential role in brain development . AFF2 belongs to a gene family that includes AF4, LAF4, and AF5q31, and shares a common ancestor with the Drosophila melanogaster gene Lilliputian .

The longest AFF2 isoform consists of 1311 amino acids and contains two nuclear localization signal sequences . The protein's structure includes multiple functional domains that facilitate its interactions with other proteins and nucleic acids. Understanding AFF2's function is crucial because disruptions in this gene have been associated with several neurodevelopmental disorders, particularly those affecting cognition and neuronal excitability.

How is AFF2 expressed across different tissues and developmental stages?

AFF2 shows distinctive expression patterns across tissues, with particularly high expression in the brain . Within the brain, expression varies by region and changes throughout development. During embryonic development, AFF2 expression coincides with critical periods of neurogenesis and synaptogenesis, suggesting its involvement in these processes.

Studies in knockout mouse models have demonstrated that complete loss of AFF2 function results in abnormal central nervous system synaptic transmission, abnormal excitatory postsynaptic potential, and premature death . This finding highlights the protein's critical role in normal brain development and function. Temporal expression analysis shows that AFF2 levels fluctuate during different developmental stages, correlating with key neurodevelopmental milestones.

What is the genomic structure of AFF2 and its isoforms?

AFF2 is a large gene with 21 exons and 6 annotated isoforms with alternative splicing among exons 2, 3, 5, and 7 . The genomic organization of AFF2 is complex, and its transcriptional regulation involves multiple mechanisms. The gene's promoter region contains a CGG repeat sequence that, when expanded, can lead to gene silencing and the FRAXE phenotype .

The various isoforms of AFF2 have distinct tissue-specific expression patterns and potentially different functions. Alternative splicing allows for functional diversity of the AFF2 protein, enabling it to participate in multiple cellular processes. Understanding the specific roles of different isoforms is an active area of research, particularly in relation to their involvement in neurodevelopmental disorders.

What evolutionary conservation patterns does AFF2 exhibit across species?

AFF2 is highly conserved across species, indicating its fundamental importance in cellular function . The Pan troglodytes (chimpanzee) AFF2 shares significant homology with human AFF2, making it a valuable model for studying the protein's function in relation to human diseases. Comparative genomics studies have identified conserved domains that likely represent functionally important regions of the protein.

The evolutionary conservation of AFF2 extends to more distant species, with a common ancestor in Drosophila melanogaster known as Lilliputian . Inactivation of the lilli gene in Drosophila generates a fly of reduced size, suggesting a role in growth regulation. This evolutionary conservation provides researchers with multiple model organisms for studying AFF2 function and dysfunction.

How do mutations in AFF2 contribute to autism spectrum disorder?

Studies have found that approximately 2.5% of males with autism spectrum disorder (ASD) have missense mutations at highly conserved evolutionary sites in the AFF2 gene . When compared with the frequency of missense mutations in unaffected controls, there is a statistically significant enrichment of these mutations in patients with ASD (OR: 4.9; P < 0.014) . This finding suggests that rare variations in AFF2 may be an important ASD susceptibility locus and may help explain some of the male excess observed in ASD.

The missense mutations associated with ASD tend to fall in regions from the nuclear localization signal 1 (NLS1) to the C-terminal of the protein . This distribution pattern differs from mutations associated with other conditions, suggesting region-specific effects of AFF2 mutations. Additionally, researchers have identified rare AFF2 3′ UTR variants at conserved sites that alter gene expression in luciferase assays . These findings indicate multiple mechanisms by which AFF2 mutations may contribute to ASD pathogenesis.

What is the relationship between AFF2 and X-linked partial epilepsy?

Five hemizygous missense AFF2 mutations have been identified in males with partial epilepsy and antecedent febrile seizures without intellectual disability or other developmental abnormalities . These mutations did not present in the controls of general populations, with an aggregate frequency significantly higher than that in control populations.

Interestingly, the missense AFF2 mutations associated with epilepsy fell into regions from the N-terminal to the nuclear localization signal 1 (NLS1), while ASD-associated missense mutations fell in regions from NLS1 to the C-terminal . This domain-specific pathogenicity suggests that different mutations in AFF2 may lead to distinct clinical phenotypes depending on which functional domain they affect. Understanding these genotype-phenotype correlations is crucial for developing targeted therapeutic approaches.

How do different types of AFF2 mutations correlate with phenotypic outcomes?

Different types of AFF2 mutations produce distinct clinical phenotypes. Intellectual disability-associated AFF2 mutations primarily consist of genomic rearrangements and CGG repeat expansions, whereas mutations associated with partial epilepsy are typically missense mutations . Complete loss of AFF2 function leads to FRAXE, a mild non-syndromic form of intellectual disability often presenting with autistic features .

The table below summarizes the correlation between AFF2 mutation types and clinical phenotypes:

Mutation TypeLocationAssociated PhenotypeReference
CGG expansionPromoterFRAXE intellectual disability
Large deletionsEntire geneSevere intellectual disability (when including FMR1)
DeletionsAFF2 locus onlyAutism and mild intellectual disability
DuplicationsAFF2 locusIntellectual disability
MissenseN-terminal to NLS1Partial epilepsy with febrile seizures
MissenseNLS1 to C-terminalAutism spectrum disorder
3′ UTR variants3′ UTRAltered gene expression, potential ASD link

This genotype-phenotype correlation suggests that hypomorphic alleles with reduced function might act as autism susceptibility loci, while complete loss of function leads to intellectual disability .

What molecular mechanisms underlie AFF2-related disorders?

The molecular mechanisms by which AFF2 mutations lead to neurodevelopmental disorders are still being elucidated, but several pathways have been implicated. As a transcriptional regulator and RNA-binding protein, AFF2 dysfunction may disrupt the expression of numerous downstream genes involved in neuronal development and function .

In mouse models, homozygous AFF2 knockout leads to abnormal central nervous system synaptic transmission, abnormal excitatory postsynaptic potential, and premature death . These findings suggest that AFF2 plays a crucial role in synaptic function and neuronal excitability. The protein's involvement in RNA splicing and mRNA processing further suggests that post-transcriptional regulation of gene expression may be a key mechanism underlying AFF2-related disorders.

What expression systems are optimal for recombinant AFF2 production?

For recombinant AFF2 production, multiple expression systems have been developed with varying advantages. After 16 years of development, researchers have established five major systems for expressing recombinant proteins, ranging from prokaryotic to eukaryotic systems . These include:

  • Escherichia coli (E. coli) - Suitable for basic protein structure studies

  • Yeast - Offers some post-translational modifications

  • Baculovirus-infected insect cells - Better for complex proteins requiring proper folding

  • Mammalian cells - Optimal for proteins requiring mammalian-specific modifications

  • Cell-free E. coli systems - Unique expression system that eliminates many traditional steps such as plasmid transformation, cell culture, collection, disruption, and centrifugation

What purification strategies are most effective for AFF2 protein?

Effective purification of AFF2 protein typically involves affinity chromatography using various tags, followed by additional purification steps to achieve high purity. Common tags include His, GST, Flag, and MBP . The choice of tag depends on the downstream application, with His-tags often preferred for structural studies and GST or MBP tags for functional assays due to their potential solubility-enhancing properties.

A typical purification protocol might involve:

  • Affinity chromatography using the appropriate tag

  • Ion exchange chromatography to separate based on charge differences

  • Size exclusion chromatography for final polishing and buffer exchange

  • Quality control checking for purity, endotoxin levels, and biological activity

For applications requiring highly pure protein, such as crystallography or cryo-electron microscopy, additional purification steps may be necessary to achieve >95% purity. Verification of biological activity is crucial, particularly for functional studies of AFF2 variants.

How can AFF2 variants be efficiently detected in clinical samples?

Detection of AFF2 variants in clinical samples has been successfully achieved through massively parallel sequencing approaches . For targeted sequencing of the AFF2 genomic region, researchers have used various strategies including:

  • PCR amplification of specific regions followed by sequencing

  • Capture-based enrichment methods to target the AFF2 locus

  • Whole exome sequencing with focused analysis on AFF2

  • Specific assays for CGG repeat expansions in the promoter region

Statistical analysis is crucial for determining the significance of identified variants. Fisher's exact test can be applied to assess the frequencies of AFF2 mutations in case cohorts compared to control populations, with a p-value < 0.05 considered statistically significant .

For analysis of conservation and predicted functional impact, tools that calculate PhyloP scores can identify variants at highly conserved evolutionary sites . Enrichment of variants with PhyloP >1 or >2 in cases versus controls can provide evidence for pathogenicity.

What functional assays are available to assess the impact of AFF2 mutations?

Several functional assays have been developed to assess the impact of AFF2 mutations:

  • Luciferase reporter assays - Particularly useful for evaluating the effects of 3′ UTR variants on gene expression

  • Protein localization studies - To determine if mutations affect the nuclear localization of AFF2

  • RNA-binding assays - To assess the impact on AFF2's RNA-binding function

  • Transcriptional activation assays - To evaluate effects on AFF2's transcriptional regulation function

  • Co-immunoprecipitation studies - To identify altered protein-protein interactions

For in vivo assessment, mouse models with specific AFF2 mutations can be valuable for understanding phenotypic consequences. Behavioral testing, electrophysiological studies, and histological analyses can provide insights into the functional effects of AFF2 mutations on brain development and function.

How can contradictory findings about AFF2 function be reconciled?

Contradictory findings regarding AFF2 function may arise from several sources, including differences in experimental systems, genetic backgrounds, and methodological approaches. To reconcile these contradictions, researchers should:

  • Consider tissue-specific effects - AFF2 may function differently in various cell types or developmental stages

  • Evaluate isoform-specific functions - Different AFF2 isoforms may have distinct or even opposing functions

  • Assess interaction partners - AFF2 function may depend on the presence of specific interaction partners that vary across experimental systems

  • Examine domain-specific effects - Mutations in different domains may lead to different or even contradictory functional outcomes

The Retrieval Augmented Generation (RAG) approach can be valuable for analyzing contradictory literature, as it can identify patterns in contradictions and potential explanations . Novel data generation frameworks can simulate different types of contradictions that may occur in research findings . This approach allows for systematic evaluation of contradictory data and development of testable hypotheses to resolve discrepancies.

What statistical approaches are appropriate for analyzing AFF2 variant frequencies?

When analyzing AFF2 variant frequencies, several statistical approaches have proven effective:

  • Fisher's exact test for comparing variant frequencies between case and control populations

  • Assessment of variation using metrics such as Θw per site and Tajima's D test statistics to identify excess rare variants

  • Evaluation of conservation using PhyloP scores to identify variants at evolutionary conserved sites

  • Population stratification analysis to ensure that observed differences are not due to ancestry differences between cases and controls

In a study of AFF2 variants in autism, researchers found a negative value for the Tajima's D test statistics, indicating an excess of rare variants . When comparing variation at conserved sites (PhyloP >2), AFF2 exhibited significant enrichment for variants in cases versus controls (P < 0.02) . These statistical approaches help distinguish pathogenic variants from benign polymorphisms.

How should researchers integrate multi-omics data to understand AFF2 biology?

Integration of multi-omics data is essential for comprehensive understanding of AFF2 biology. This approach should include:

  • Genomics - Identification of variants and their population frequencies

  • Transcriptomics - Analysis of AFF2 expression patterns and splicing events

  • Proteomics - Characterization of AFF2 protein interactions and post-translational modifications

  • Epigenomics - Evaluation of regulatory mechanisms affecting AFF2 expression

  • Functional genomics - CRISPR-based screens to identify synthetic lethal interactions

Data integration can be achieved through various computational approaches, including network analysis, pathway enrichment, and machine learning methods. Visualization tools can help identify patterns and relationships across different data types. This integrated approach is particularly valuable for understanding complex phenotypes associated with AFF2 mutations, where multiple downstream pathways may be affected.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.